Pfizer applies for U.S. emergency use for COVID-19 vaccine

Pfizer Inc. said Friday it has applied to U.S. health regulators for emergency use authorization (EUA) of its COVID-19 vaccine, a major step toward providing protection against the new coronavirus for pandemic-weary Americans.

The application to the U.S. Food and Drug Administration (FDA) comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing COVID-19 with no major safety concerns.

Pfizer’s shares rose 2% and BioNTech climbed 5% on the news that a vaccine could soon be available, raising hopes for the end of a pandemic that has claimed more than a quarter of a million lives in the United S…

Keep on reading: Pfizer applies for U.S. emergency use for COVID-19 vaccine

Must Read

Step up police searches, checkpoints to stem influx of marijuana, says...

0
MANILA, Philippines --- Police officers must intensify searches at checkpoints as marijuana, believed to being used as an alternative to shabu, is being transported...